Literature DB >> 21527754

Amyloid beta enhances migration of endothelial progenitor cells by upregulating CX3CR1 in response to fractalkine, which may be associated with development of choroidal neovascularization.

Jiying Wang1, Kyoko Ohno-Matsui, Ken-ichi Nakahama, Aikou Okamoto, Takeshi Yoshida, Noriaki Shimada, Manabu Mochizuki, Ikuo Morita.   

Abstract

OBJECTIVE: Deposits that accumulate beneath retinal pigment epithelium, called drusen, are early signs of age-related macular degeneration (AMD). We have shown that amyloid β (Aβ) is present in drusen, and Aβ may be involved in AMD development. We have also shown that endothelial progenitor cells (EPCs) may contribute to the development of choroidal neovascularization (CNV). Thus, the purpose of this study was to investigate the role played by CX3CR1, a chemokine receptor, in EPC migration and CNV formation. METHODS AND
RESULTS: EPCs collected from human umbilical cords were found to express higher levels of CX3CR1 than human umbilical vein endothelial cells, and exposure of EPCs to Aβ caused further upregulation of CX3CR1. This upregulation was decreased by blocking fractalkine, a ligand of CX3CR1. Exposure of EPCs to fractalkine increased their migration, but pretreatment with Aβ enhanced the migration. The fractalkine-induced EPC migration was more inhibited by EPCs derived from CX3CR1(-/-) mice than wild-type mice. The area of laser-induced CNV was significantly smaller in wild-type mice that received bone marrow transplantation from CX3CR1(-/-) mice than in those that received transplantation from wild-type mice.
CONCLUSIONS: These data suggest that Aβ enhances EPC migration through the upregulation of CX3CR1. This upregulation might play a role in development of CNV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527754     DOI: 10.1161/ATVBAHA.110.215517

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  8 in total

1.  Transcriptomic analysis of frontotemporal lobar degeneration with TDP-43 pathology reveals cellular alterations across multiple brain regions.

Authors:  Rahat Hasan; Jack Humphrey; Conceição Bettencourt; Jia Newcombe; Tammaryn Lashley; Pietro Fratta; Towfique Raj
Journal:  Acta Neuropathol       Date:  2021-12-28       Impact factor: 17.088

2.  Prospective study of common variants in CX3CR1 and risk of macular degeneration: pooled analysis from 5 long-term studies.

Authors:  Debra A Schaumberg; Lynda Rose; Margaret M DeAngelis; Richard D Semba; Gregory S Hageman; Daniel I Chasman
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

3.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Authors:  Vincent Lambert; Julie Lecomte; Sylvain Hansen; Silvia Blacher; Maria-Luz Alvarez Gonzalez; Ingrid Struman; Nor Eddine Sounni; Eric Rozet; Pascal de Tullio; Jean Michel Foidart; Jean-Marie Rakic; Agnès Noel
Journal:  Nat Protoc       Date:  2013-10-17       Impact factor: 13.491

4.  Neuronal Cx3cr1 Deficiency Protects against Amyloid β-Induced Neurotoxicity.

Authors:  Jenny Dworzak; Benoît Renvoisé; Johnny Habchi; Emma V Yates; Christophe Combadière; Tuomas P Knowles; Christopher M Dobson; Craig Blackstone; Ole Paulsen; Philip M Murphy
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

5.  Effects of concentration of amyloid β (Aβ) on viability of cultured retinal pigment epithelial cells.

Authors:  Naonori Masuda; Hiroki Tsujinaka; Hiromasa Hirai; Mariko Yamashita; Tetsuo Ueda; Nahoko Ogata
Journal:  BMC Ophthalmol       Date:  2019-03-08       Impact factor: 2.209

Review 6.  Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X7R signaling.

Authors:  Pavithra Suresh; Sarayut Phasuk; Ingrid Y Liu
Journal:  Tzu Chi Med J       Date:  2021-01-05

7.  "Endothelial Antibody Factory" at the Blood Brain Barrier: Novel Approach to Therapy of Neurodegenerative Diseases.

Authors:  Reynald Thinard; Attila E Farkas; Marta Halasa; Melanie Chevalier; Klaudia Brodaczewska; Aleksandra Majewska; Robert Zdanowski; Maria Paprocka; Joanna Rossowska; Lam Tri Duc; Ruth Greferath; Istvan Krizbai; Fred Van Leuven; Claudine Kieda; Claude Nicolau
Journal:  Pharmaceutics       Date:  2022-07-06       Impact factor: 6.525

Review 8.  Bone marrow-derived cells in ocular neovascularization: contribution and mechanisms.

Authors:  Fan Gao; Huiyuan Hou; Hongliang Liang; Robert N Weinreb; Haiyan Wang; Yusheng Wang
Journal:  Angiogenesis       Date:  2016-02-15       Impact factor: 9.596

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.